Clinical Trial Update: A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hydroxychloroquine sulfate for reducing proteinuria in IgA nephropathy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• Hydroxychloroquine sulfate (Hydroxychloroquine sulfate)

Snippet

Sponsor: Peking University First Hospital | Conditions: IgA Patients, Hydroxychloroquine | Phase 2 | Status: COMPLETED